Moreover, other reports have shown that cetuximab attenuated cell invasion/metastasis-related processes in gastric cancer, whereas E-cadherin protein expression correlated with cetuximab sensitivity in non-small cell lung cancer (NSCLC) [12,13]. The gene discussed is CDH1; the disease is non-small cell lung carcinoma.